STRATTEC SECURITY CORPORATION names senior automotive parts executive as CEO
MILWAUKEE, June 14, 2024 (GLOBE NEWSWIRE) — The Board of Directors (“Board”) of STRATTEC SECURITY CORPORATION (NASDAQ:STRT) (the “Company”) is […]
LiveOne (Nasdaq: LVO) Announces 244th Edition of LiveOne Presents as Streaming Partner for “The Game of Legends” from Culture by Futbol
Soccer Legends Ronaldinho and Kaka to Electrify Toyota Arena in Groundbreaking MASL Celebrity Match with KidSuper & MoAliFC LiveOne Partner […]
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
RADNOR, Pa., June 14, 2024 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing […]
Hurco Companies, Inc. Announces Suspension of Quarterly Cash Dividend
INDIANAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq Global Select Market: HURC) (“Hurco” or the “Company”), an […]
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
LONDON, June 14, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical […]
Treasure Global Inc Announces New Chief Executive Officer
NEW YORK and KUALA LUMPUR, Malaysia, June 14, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“Treasure Global” or […]
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
Patients treated with 100 mg bezuclastinib showed substantial reduction in their most severe symptoms and mast cell reactions Reductions were […]
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Notes due 2026
SINGAPORE, June 14, 2024 (GLOBE NEWSWIRE) — JOYY Inc. (Nasdaq: YY) (“JOYY” or the “Company”), a global technology company, today […]
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
Updated analyses of data from AURORA and BEACON studies further demonstrate clinical activity of bitopertin across multiple measures of erythropoietic […]
Intellia Therapeutics Names Brian Goff to its Board of Directors
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on […]
